Aurobindo Pharma Limited Share Price and Company Fundamentals
Last traded: Today at 9:59 AM
Aurobindo Pharma Limited, a biopharmaceutical company, develops, manufactures, commercializes, and sells generic pharmaceuticals, active pharmaceutical ingredients (APIs), and injectables. The company offers formulation in form of oral solids, liquids, injectables, vaccines, and metered dose inhalers; and APIs, biosimilars, and peptides targeting therapeutic areas, such as central nervous system, cardiovascular, respiratory, antibiotics, anti-retroviral, anti-diabetics, gastroenterology, oncology, and dermatology. It also provides antiretroviral drugs for the people and children living with HIV; and API space for sterile and non-sterile penicillin's, cephalosporins, penems, and non-beta lactams. The company has operations in India, the United States, Europe, Puerto Rico, and internationally. The company was incorporated in 1986 and is headquartered in Hyderabad, India.
Key Metrics
PE ratio
20.51
PB ratio
2.04
Dividend yield
0.33%
Beta
0.06
Market cap
₹715.49B
Enterprise value
₹700.86B
Company profile
| Industry / Sector | Drug Manufacturers - Specialty & Generic / Healthcare |
|---|---|
| Full time employees | 27707 |
| Website | https://www.aurobindo.com |
| Mailing address | Galaxy, Plot No. 1 22nd-24th Floor, Survey No.83/1 Hyderabad Knowledge City, Raidurg Panmaktha Rangareddy District Hyderabad 500032 India |
| Phone / Fax | 91 40 6672 5000 / 91 40 6707 4044 |
Dividends
Dividend yield
0.33%
Dividend amount
₹4.00
Payout ratio
6.66%
5Y Avg. yield
-%
Aurobindo Pharma Limited paid ₹4.00 dividend and the ex-dividend date was 08 Aug 2025.The dividend payout ratio is 6.66%. The dividend payout ratio is defined as the amout of dividend paid divided by the earnings of the company.AUROPHARMA dividend payout ratio is less than 70. This is ideal as it gives company room to grow the dividends and also the excess earnings can be invested in company for growth.
Company Executives
As of Mar 2026, following are the company executives and directors listed on Aurobindo Pharma Limited.
| Name | Title | Age | Total Pay |
|---|---|---|---|
| Mr. Kambam Nithyananda Reddy | Vice Chairman & MD | 67 | |
| Mr. Mettu Madan Mohan Reddy | Whole-Time Director | 65 | |
| Dr. Makkapati Satakarni B.E., M.B.A., Ph.D. | President of Biologics, CEO of Biologics, Vaccines and Peptid & Director | 44 | |
| Mr. Santhanam Subramanian | Chief Financial Officer | 64 | |
| Mr. Mula Surya Narayana Murthy | Senior Vice President of Accounts | ||
| Dr. S. Vijaya Kumar | President of Technical | 59 | |
| Dr. Parveen Kumar Luthra | Chief Scientific Officer | 54 | |
| Mr. Ilapakurty S R . Chandra Rao | Senior Vice President of Admin | ||
| Mr. Baddigam Adi Reddy | Compliance Officer & Company Secretary | ||
| Dr. K. Suresh Kumar | Associate President of HR |
Profitability and management effectiveness
Profit margin
10.51%
Operating margin
15.14%
Return on assets
-
Return on equity
-
Profitability ratios are a class of financial metrics that are used to assess a business's ability to generate earnings relative to its revenue, operating costs, balance sheet assets, and shareholders' equity over time, using data from a specific point in time.
The return on equity signifies how well the management is running the company in terms of capital management. The ideal return on equity is greater than 10%. The return on equity is calculated as net income divided by total share holders equity.
Valuation and Trading Info
The market capitalization of Aurobindo Pharma Limited is 715.49B and its enterprise value is 700.86B. The enterprise value to revenue ratio of AUROPHARMA is 2.11. The enterprise value to EBITDA ratio of AUROPHARMA is 10.48.
The AUROPHARMA's stocks Beta value is 0.06 making it 94% less volatile compared to NSE market index. Technology stocks and small caps tend to have higher betas than the market benchmark. This indicates that adding the stock to a portfolio will increase the portfolio’s risk, but also increase its expected return. On the other hand utility stocks often have low betas because they tend to move more slowly than market averages.
Aurobindo Pharma Limited (NSE:AUROPHARMA) Frequently Asked Questions
1. What is Aurobindo Pharma Limited's Stock Symbol?
Aurobindo Pharma Limited trades on NSE under the ticker symbol "AUROPHARMA".
2. What is Aurobindo Pharma Limited's stock price today?
One share of AUROPHARMA stock can currently be purchased for approximately ₹1231.9.
3. How can I contact Aurobindo Pharma Limited?
Aurobindo Pharma Limited's mailing address is Galaxy, Plot No. 1 22nd-24th Floor, Survey No.83/1 Hyderabad Knowledge City, Raidurg Panmaktha Rangareddy District Hyderabad 500032 India. The company can be reached via phone at 91 40 6672 5000.
4. What is Aurobindo Pharma Limited's official website?
The official website of Aurobindo Pharma Limited is https://www.aurobindo.com.